Free Content Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China [Short communication]

(PDF 230kb)
Download Article:


Multidrug-resistant tuberculosis (MDR-TB) is a growing problem in China. In 2008, all smear-positive pulmonary TB patients in a city in northern China were expected to undergo routine culture and drug susceptibility testing (DST). We assessed the performance of this system. There were 915 patients, of whom 356 (39%) had culture performed; 275 (30%) had positive cultures and 236 (26%) had DST. Of the 236 patients with DST, 6% of new and 32% of previously treated patients had MDR-TB. Culture and DST is an important service for the correct management of patients, and solutions to improve the current system need to be considered.

Keywords: China; culture; drug susceptibility testing; multidrug-resistant tuberculosis

Document Type: Short Communication

Affiliations: 1: Tianjin Centres for Disease Control and Prevention, Tianjin, China 2: International Union Against Tuberculosis and Lung Disease, Paris, France; London School of Hygiene & Tropical Medicine, London, UK 3: International Union Against Tuberculosis and Lung Disease, Paris, France; University of Bergen, Bergen, Norway

Publication date: January 1, 2011

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • ingentaconnect is not responsible for the content or availability of external websites
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more